Dr Piers Patten

Mr Piers Patten is a UK-trained clinical haematologist. They provide clinical services for the King's Health Partners lymphoma service. They are particularly interested in chronic lymphocytic leukaemia (CLL), a common lymphoma subtype. Mr Patten is very actively involved in clinical trials for CLL and other lymphomas through full participation in the National Cancer Research Institute portfolio and commercial studies.

Further, they continue to undertake laboratory research at KCL investigating these lymphoid disorders, collaborating with national and international researchers. Through membership of the NCRI CLL CSG sub-group and UK CLL Forum Executive they further ensure that clinical and laboratory research, education and advocacy in this disease is maintained at a national level. Mr Patten is fully trained in the assessment of patients for, and delivery of, CAR-T therapy, a highly specialised new therapy that has recently been licenced for certain patients with relapsed high grade B cell lymphomas and acute lymphoblastic leukaemia.